The Medical Device Commercialisation Training Program (MDCTP) is delivered by Cicada Innovations in partnership with NSW Health, the program funder. The program is designed to accelerate commercialisation of medical technologies in NSW to bring lifesaving healthcare innovations to patients, hospitals and governments around the world.

The MDCTP offers an invaluable opportunity to NSW based medical device technologists to build knowledge, skills and network needed to successfully commercialise medical device technologies. 

There are three course streams available as part of the MDCTP to meet the needs of medical technologists at different stages of their journey that build upon each other:

  • CORE, our flagship course;

  • IP / Regulatory / Clinical Trial Workshops; and

  • Health Discovery

Applicants may apply from Startups, Universities, Research Institutes, the NSW Health System and Industry.


MDCTP CORE is designed for healthcare entrepreneurs from diverse backgrounds of medicine, engineering, science and business, and provides a tailored curriculum on how to transform their visionary concepts into viable businesses. 

Since 2014, 80 graduates of CORE have launched 15 companies and raised over $53M to commercialise their ideas. Graduates of CORE are eligible for post-program support with the following awards available (total value >$1000,000):

  • 2 x Scholar Program Awards to relocate to the Rosenmann Institute QB3 California Institute for Quantitative Biosciences, USA, for 2 years

  • Product Development Award 

  • International Discovery Grants 

  • Intellectual Property Strategy Award

  • Regulatory Strategy Award 

  • Cicada Innovations Incubation Award

Course Specifications

Through a series of workshops and events, CORE candidates will learn to “search” for the right business model for their technologies based on Lean LaunchPad methodologies and gain insights from over 30 mentors and domain experts on every facet of running a health related business: 

  • Intellectual Property

  • Regulatory and Reimbursement Strategies 

  • Financial Modelling and Pricing

  • Valuation

  • Capital Raising 

  • Business Governance 

  • Pitch Crafting

  • Negotiation and Influence. 

The course is modelled on experiential learning and a flipped classroom approach to engage candidates with real world entrepreneurship. This involves experimentation; getting out of the classroom and talking to customer, partners and competitors. 

Course Expectations

MDCTP CORE is structured in two parts; the “search” for the right business model and the ‘structural’ of aspects critical to medical device commercialisation. Candidates are expected to work in teams for the “search” component of the course, conducting customer interviews on the Team Lead’s technology, to develop skills to apply to their own technology. Candidates will work on their own technologies for the “structural” component of the course. 

MDCTP CORE requires a commitment of attending 1 full day per week for 12 weeks at Cicada Innovations in Sydney, up to 20 hours per week of customer interviews and homework and attending the graduation showcase in May 2018. 


Free! There is no cost for participants or their institutions as the Medical Device Commercialisation Training Program is funded by NSW Health, Office for Health and Medical Research.

Applications for CORE 2019 are open now

16 Sep 19 – Applications Open

27 Oct 19 – Applications Close

11 Nov 19 – Selection Interviews

03 Feb 20 – CORE Start

03 May 20 – CORE Finish

Late May 20 – Graduation and Showcase 

NSW Medical Device Commercialisation Training Program 2019


The MDCTP has proven its strategic value to the development of medical technology commercialisation capability within NSW over the past four years. In this short time graduates have launched new businesses, secured investment, developed and launched devices into the market, created skilled jobs and advanced their skills as professional innovators.



MDCTP IP is a one-day workshop delivered together with Australia’s leading intellectual property firm, Davies Collison Cave, that focuses on intellectual property management strategies for medical devices. It is designed to equip candidates with the necessary knowledge to protect their intellectual property through trademarks, patents and design registration. Candidates will learn about the different types of intellectual property, protection strategies and how to speak about their medical research or technology without giving away their secret sauce.

MDCTP IP workshops are free to participants.

MDCTP IP courses run four times per year.  The next available IP workshop will be held at Cicada Innovations on 20th September 2019 from 9:00-17:00. 


This workshop will take a deep dive into the global regulatory requirements for medical devices and diagnostics.  We will look at the technical requirements and international standards based framework for regulation, and how this is implemented through different international regulatory regimes including Conformity Assessments for Europe/Australia/Canada and 510(k)/PMA processes for the US FDA. Attendees will come away with a Global perspective on regulation including:

  • How to do product development right - so that the process delivers regulatory compliance

  • How to engage with regulators – including premarket consultations – to make sure you are on the right track\How to put together a technical file and how to prepare a regulatory dossier

  • The central importance of clinical evidence

  • How postmarket regulatory responsibilities continue on after registration – including adverse event reporting, advertising compliance and safety alerts and recalls processes.

Your presenter:

Arthur Brandwood is Founder and Principal Consultant of Brandwood Biomedical: an international medical device and IVD regulatory consultancy headquartered in Sydney and with offices in US and across Asia Pacific.

Arthur has spent more than 30 years in the devices industry. He has worked on biomaterials and device developments for both startup and large multinational companies and in university applied research.

Arthur has held senior roles in government including Director of Device Registrations and Assessment at TGA, represented the industry to government as Chair of the Regulatory expert panel for AusMedtech and for the last 18 years has provided expert consulting services and training to companies and to regulatory agencies across the Asia Pacific.  He is currently visiting Professor at the University of Sydney where he teaches regulatory affairs to biomedical engineers.

Arthur combines his deep knowledge and experience of global regulatory processes with a passion for communication and training to deliver what will be an engaging training event.

The next Regulatory workshop will be held at Cicada Innovations. Please stay tuned for the next workshop dates. 


Designed for medical entrepreneurs, researchers and clinical staff who want to understand more about the steps in developing a clinical trial from idea through to protocol, this 1-day workshop with Southern Star Research and Cicada Innovations will explore concepts such as:

  • Regulations Governing Clinical Trials in Australia

  • Setting up a Clinical Trial – insight into clinical trial protocols, site and CRO selection, ethical approval, budgeting and contracts

  • Device vigilance in the context of clinical trials

  • Biometrics departments and why you need them. Key roles and responsibilities

  • What you need to effectively resource a study and;

  • Hints and tips on where to find funding to get your trial off the ground.

At completion, participants will recognise the key milestones in progressing a clinical trial from idea through to clinical trial reporting.

The next available Clinical Trails Workshop will be held at Cicada Innovations on 26th September 2019 from 9:00-17:00. 

Registrations are now closed for the Clinical Trials Workshop. Stay tuned for 2019 Workshops



The MDCTP course has been an incredibly valuable opportunity both for Sheridan and myself, giving us a sound basis from which to build our business, especially noting the importance of customer validation. The course has taught us not only what we should be doing now, but also what we should be preparing for. In the world of startups, timing can be critical and being aware and prepared helps to avoid falling into unwarranted regulatory, legal or other pitfalls down the track.

The commercialisation game is hard enough to play, and flying blind without a comprehensive understanding of the fundamentals is a recipe for failure. The MDCTP course gave us the momentum we needed to get out of the research facility and amongst the people we are trying to help and those that can help us make it happen.” 
Michael Weaver, Co-founder at Cenofex Innovations (Awarded the NSW-QB3 Rosenman Institute Program scholarship, MDCTP 2014).


The MDCTP was invaluable in teaching me how to commercialise a medical device and putting me in touch with key contacts within the field. I also learnt how to ‘pitch’. During the course my team worked on the ‘business model canvas’ for Kleer-i a sutureless surgery for the eye which helped with our successful application to the Medical Devices Fund.” 
Stephanie Watson, Eye Surgeon at Save Sight Institute, Founder at Kleer-i (Awarded with $50,000 Seed Funding, MDCTP 2015).


The MDCTP provided me with, not only the knowledge, but the experience of testing the validity of your idea in a market. We learnt the basics of many aspects necessary in commercialising a product and became familiar with the language used – this has already been of value in my role. But the key value of the course to me is that I now feel enabled to take an idea and systematically ask – does it solve a problem? for whom? and specifically what do I need to do to get it to them, and make a profit? I would certainly recommend it to people interested in commercialising their ideas, in fact I already do.” 
Stephen Bradford, Research Scientist in Genomics at CSIRO/Garvan Institute of Medical Research.



How is ‘medical device’ defined?
Any type of device, instrument, diagnostic, app, software or processing technology that aims to improve patient or health system outcomes. We do not accept pharmaceutical drugs.

What happens to my intellectual property during the course?
Non-disclosure agreements are signed by all parties involved in the course, and we do not require you to reveal any sensitive information. Background intellectual property remains with their original owners.



For further information please contact Dharmica Mistry via Applications will only be accepted via the application form and will not be considered if they are sent via email.